“The pharmaceutical patent process: National Health Surveillance Agency and National Institute of Industrial Property act differently in the process” (2024) International Journal of Advances in Medical Biotechnology - IJAMB, 6(1), pp. 53–50. doi:10.52466/ijamb.v6i1.116.